Daemyung Chemical maintains 67.75% stake in LOGEN; partial amendment of stock pledge contracts reduces pledged shares to 47.00%
Daemyung Chemical maintains its status as the largest shareholder of LOGEN with 38,047,192 shares or 67.75% unchanged from the previous report.
Partial amendment of existing stock pledge contracts including maturity extension and partial repayment reduced total pledged shares from 27,246,366 shares 48.52% to 26,394,645 shares 47.00%, a decrease of 1.52 percentage points.
No new share issuance or convertible bonds were involved; only changes to existing pledge contract terms, so there is no dilution risk to shareholder value.
[AI Summary]This filing reports only a partial amendment of stock pledge contracts with no change in Daemyung Chemical's stake in LOGEN. While pledged shares decreased slightly, the substantive impact on management control and stock price is limited, making this a neutral event.